Acarix A/S was established in 2009 as a spinout from Coloplast A/S. Since 2010 key investors SEED Capital Denmark and Sunstone Life Science Ventures have financed the company and supported it towards market introduction. Acarix is a medical device company specializing in non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD).